Recruiting

Data and Sample Collection from Healthy Volunteers for Translational Research

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study collects various samples like blood, urine, and skin biopsies from healthy volunteers to support research that helps understand and develop new medical treatments.

What is being collected

Data Collection

Who is being recruted

From 18 to 85 Years
+22 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: December 2004
See protocol details

Summary

Principal SponsorNational Institute of Allergy and Infectious Diseases (NIAID)
Study ContactThomas W Brown, R.N.More contacts
Last updated: January 17, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: December 9, 2004

Actual date on which the first participant was enrolled.

This study aims to collect data and samples from healthy individuals to aid in research on eosinophilia and parasitic diseases. The study recruits healthy volunteers who meet specific eligibility criteria to donate samples like blood, urine, and other body fluids or tissues. The purpose of gathering these samples is to use them in laboratory research to better understand certain medical conditions. This research is important because it can help develop new treatments and improve understanding of diseases that have unmet medical needs. Healthy volunteers provide a control group, especially for conditions that require comparisons to individuals without asthma or allergies. Participants in this study are asked to undergo certain tests and donate samples using standard medical procedures. Tests may include non-invasive techniques like infrared thermography or a test to check the esophagus. Volunteers are fully informed about the nature of the study, including any risks or benefits, and they provide written consent before participating. Compensation is provided based on the time and any discomfort experienced during the donation process. The samples collected are only used for laboratory research, and each sample is labeled with a unique code to protect the donor's identity. The study ensures that all participants' rights and safety are protected following strict regulatory standards.

Official TitleCollection of Data and Samples From Healthy Donors for Use in Translational Research 
NCT00090662
Principal SponsorNational Institute of Allergy and Infectious Diseases (NIAID)
Study ContactThomas W Brown, R.N.More contacts
Last updated: January 17, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

150 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 85 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

6 inclusion criteria required to participate
healthy male or female

18-85 years of age

healthy, male or female

18-65 years of age

Show More Criteria

16 exclusion criteria prevent from participating
weight <110 pounds

history of heart, lung, kidney disease, chronic anemia or bleeding disorders

a known bleeding disorder, low platelets (<100k) or taking medications that interfere with blood clotting, such as aspirin, non-steroidal anti-inflammatory agents or warfarin

anemia (hemoglobin less than 12.3 mg/dL)

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

National Institutes of Health Clinical Center

Bethesda, United StatesSee the location
Recruiting
One Study Center